Sharps Technology to Present at the Aegis Capital Corp. 2025 Virtual Conference on May 22nd
Sharps Technology (NASDAQ: STSS), a medical device and pharmaceutical packaging company specializing in smart-safety syringe products, announced that CEO Robert Hayes will present at the Aegis Capital Corp. 2025 Virtual Conference on May 22, 2025, at 1:00 p.m. ET.
The company focuses on ultra-low waste capabilities with passive and active safety features in their syringe technologies. Sharps also offers products with specialized copolymer technology for the prefillable syringe market segment and operates a manufacturing facility in Hungary.
Sharps Technology (NASDAQ: STSS), un'azienda specializzata in dispositivi medici e imballaggi farmaceutici focalizzata su prodotti per siringhe con sicurezza intelligente, ha annunciato che l'amministratore delegato Robert Hayes parteciperà alla Aegis Capital Corp. 2025 Virtual Conference il 22 maggio 2025 alle 13:00 ET.
L'azienda si concentra su capacità di riduzione ultra-bassa degli sprechi con caratteristiche di sicurezza passive e attive nelle loro tecnologie per siringhe. Sharps offre inoltre prodotti con tecnologia copolimero specializzata per il segmento di mercato delle siringhe pre-riempibili e gestisce uno stabilimento produttivo in Ungheria.
Sharps Technology (NASDAQ: STSS), una empresa de dispositivos médicos y empaques farmacéuticos especializada en productos de jeringas con seguridad inteligente, anunció que el CEO Robert Hayes presentará en la Conferencia Virtual Aegis Capital Corp. 2025 el 22 de mayo de 2025 a la 1:00 p.m. ET.
La compañía se enfoca en capacidades de ultra bajo desperdicio con características de seguridad pasivas y activas en sus tecnologías de jeringas. Sharps también ofrece productos con tecnología de copolímero especializada para el segmento de mercado de jeringas prellenables y opera una planta de fabricación en Hungría.
샤프스 테크놀로지(NASDAQ: STSS)는 스마트 안전 주사기 제품을 전문으로 하는 의료기기 및 제약 포장 회사로, CEO 로버트 헤이즈가 Aegis Capital Corp. 2025 가상 컨퍼런스에서 2025년 5월 22일 오후 1시(동부시간)에 발표할 예정이라고 발표했습니다.
이 회사는 주사기 기술에서 수동 및 능동 안전 기능과 함께 초저폐기물 능력에 중점을 두고 있습니다. 샤프스는 또한 사전 충전 주사기 시장 부문을 위한 특수 공중합체 기술 제품을 제공하며 헝가리에 제조 시설을 운영하고 있습니다.
Sharps Technology (NASDAQ : STSS), une entreprise spécialisée dans les dispositifs médicaux et l’emballage pharmaceutique, notamment les seringues intelligentes de sécurité, a annoncé que son PDG Robert Hayes présentera lors de la Conférence virtuelle Aegis Capital Corp. 2025 le 22 mai 2025 à 13h00 (heure de l’Est).
L’entreprise se concentre sur des capacités de déchets ultra faibles avec des caractéristiques de sécurité passives et actives dans leurs technologies de seringues. Sharps propose également des produits avec une technologie de copolymère spécialisée pour le segment du marché des seringues préremplies et exploite une usine de fabrication en Hongrie.
Sharps Technology (NASDAQ: STSS), ein Unternehmen für medizinische Geräte und pharmazeutische Verpackungen, das sich auf intelligente Sicherheits-Spritzenprodukte spezialisiert hat, gab bekannt, dass CEO Robert Hayes auf der Aegis Capital Corp. 2025 Virtual Conference am 22. Mai 2025 um 13:00 Uhr ET sprechen wird.
Das Unternehmen konzentriert sich auf ultra-niedrige Abfallkapazitäten mit passiven und aktiven Sicherheitsmerkmalen in seinen Spritzentechnologien. Sharps bietet außerdem Produkte mit spezieller Copolymer-Technologie für den Markt der vorgefüllten Spritzen an und betreibt eine Produktionsstätte in Ungarn.
- None.
- None.
Presentation to be webcast at 1:00 p.m. ET
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry, today announced that Robert Hayes, CEO, is scheduled to present at the Aegis Capital Corp. 2025 Virtual Conference on May 22, 2025 at 1:00 p.m. ET.
Presentation Details:
- Presenter: Robert Hayes, CEO
- Date: May 22, 2025
- Time: 1:00 p.m. ET
- Webcast: Register Here
About Sharps Technology:
Sharps Technology is an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry. The Company’s product lines focus on providing ultra-low waste capabilities, that incorporate syringe technologies that use both passive and active safety features. Sharps also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The Company has a manufacturing facility in Hungary. For additional information, please visit www.sharpstechnology.com.
FORWARD-LOOKING STATEMENTS:
This press release contains “forward-looking statements”. Forward-looking statements reflect our current view about future events. When used in this press release, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” “poised” or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements, include, but are not limited to, statements contained in this press release relating to our business strategy, our future operating results and liquidity, and capital resources outlook. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, without limitation, our ability to raise capital to fund continuing operations; our ability to protect our intellectual property rights; the impact of any infringement actions or other litigation brought against us; competition from other providers and products; our ability to develop and commercialize products and services; changes in government regulation; our ability to complete capital raising transactions; and other factors relating to our industry, our operations and results of operations. Actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee future results, levels of activity, performance, or achievements. The Company assumes no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.
Investor Contact:
Holdsworth Partners
Adam Holdsworth
Phone: 917-497-9287
Email: IR@sharpstechnology.com
FAQ
When is Sharps Technology (STSS) presenting at the Aegis Capital Corp. Conference?
What are the main products of Sharps Technology (STSS)?
Where does Sharps Technology (STSS) manufacture its products?
What stock exchange is Sharps Technology listed on?
